Development asset linked to Beijing Cotimes Biotech in public FDA and regional records.
pharma · Human Immunodeficiency Virus
Beijing Cotimes Biotech
Beijing 302 Hospital
Beijing Cotimes Biotech drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Beijing, CN HQ
3 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 3
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Beijing Cotimes Biotech pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Beijing Cotimes Biotech drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.